The annual meeting of the American College of Gastroenterology was held from Oct. 24 to 29 in Phoenix, attracting participants from around the world, including gastroenterology and digestive disease ...

Novo Nordisk (NVO) and Eli Lilly (LLY) are nearing a deal with the White House on obesity drug pricing, with initial reports suggesting that the companies will price obesity drugs at $149 per month ...

Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited ...

A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight reduction than placebo over 64 weeks in adults with overweight or obesity. Rising ...

Orforglipron was found to be superior to oral semaglutide in lowering HbA1c. Topline results were announced from a phase 3 head-to-head study comparing an investigational oral glucagon-like peptide-1 ...

Does compounded Semaglutide work for weight loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it’s important to understand ...

According to Novo Nordisk, this study was the first to compare these GLP-1 receptor agonists in a real-world setting. Findings from a real-world study evaluating cardiovascular disease-related ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy ®) achieved significant weight loss, with one in three study participants losing 20% or more body weight 1 ** Oral semaglutide 25 mg ...

In the study, "Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity: The HISTORI Randomized Clinical Trial," published in JAMA Psychiatry, researchers ...

Martin Whyte does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

People taking semaglutide report far fewer obsessive thoughts about food, with cravings dropping sharply and mental health improving. This new research hints the drug may offer freedom from the ...